Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

NEURL4 Inhibitors

NEURL4 inhibitors are a class of chemical compounds designed to specifically target and block the activity of NEURL4, a crucial enzyme in cellular processes. NEURL4, short for Neuralized E3 Ubiquitin Protein Ligase 4, plays a pivotal role in regulating the ubiquitin-proteasome system, which is responsible for the targeted degradation of proteins within the cell. This class of inhibitors is primarily utilized in scientific research and drug discovery efforts to better understand the biological functions associated with NEURL4 and its downstream effects on cellular homeostasis.

NEURL4 inhibitors involves binding to the active site of NEURL4, preventing it from performing its ubiquitin ligase function. This, in turn, disrupts the ubiquitination and subsequent degradation of specific target proteins, leading to the accumulation of these proteins within the cell. Researchers employ NEURL4 inhibitors to elucidate the consequences of inhibiting NEURL4-mediated protein degradation, enabling the study of various cellular pathways and functions. By selectively inhibiting NEURL4, scientists can investigate the impact on protein stability, cellular signaling, and protein-protein interactions. This class of inhibitors plays a vital role in advancing our knowledge of cellular biology.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

Proteasome inhibitor that prevents the degradation of ubiquitinated proteins, thus indirectly affecting NEURL4 activity.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

A proteasome inhibitor that can stabilize proteins targeted by NEURL4 for degradation.

Lactacystin

133343-34-7sc-3575
sc-3575A
200 µg
1 mg
$188.00
$575.00
60
(2)

Specific inhibitor of the proteasome that would increase levels of proteins ubiquitinated by NEURL4.

Carfilzomib

868540-17-4sc-396755
5 mg
$41.00
(0)

Irreversible proteasome inhibitor, leading to accumulation of substrates of E3 ligases like NEURL4.

MLN 4924

905579-51-3sc-484814
1 mg
$286.00
1
(0)

Inhibits NEDD8-activating enzyme, affecting ubiquitin-like protein neddylation and can indirectly affect NEURL4 activity.

Epoxomicin

134381-21-8sc-201298C
sc-201298
sc-201298A
sc-201298B
50 µg
100 µg
250 µg
500 µg
$137.00
$219.00
$449.00
$506.00
19
(2)

A natural product that selectively inhibits proteasome activity, thereby influencing NEURL4 function.

Ixazomib

1072833-77-2sc-489103
sc-489103A
10 mg
50 mg
$311.00
$719.00
(0)

A small-molecule proteasome inhibitor, which can indirectly affect the function of NEURL4.

Oprozomib

935888-69-0sc-477447
2.5 mg
$280.00
(0)

An orally bioavailable proteasome inhibitor that can impact the pathway in which NEURL4 is involved.

Delanzomib, free base

847499-27-8sc-396774
sc-396774A
5 mg
10 mg
$160.00
$300.00
(0)

A proteasome inhibitor that might alter the degradation pathway involving NEURL4.

Ubiquitin E1 Inhibitor, PYR-41

418805-02-4sc-358737
25 mg
$360.00
4
(1)

An inhibitor of ubiquitin activating enzyme E1, which could indirectly affect NEURL4's role in ubiquitination.